New Delhi, Aug 5 (PTI) Drug firm Strides Pharma Science on Wednesday reported over four-fold rise in its consolidated net profit at Rs 101.84 crore for the quarter ended June 30, 2020, mainly on account of a one-time gain.

The company had posted a net profit of Rs 25.36 crore in the corresponding period of the previous fiscal, Strides Pharma Science said in a filing to the BSE.

Also Read | Assam Lottery Results Today: Check Lucky Draw Results of Assam Future Kind, Assam Singam Green, Assam Kuil Gold on August 5, 2020 Online at assamlotteries.com.

Total income of the company stood at Rs 794.10 crore in the quarter under consideration. It was at Rs 696.05 crore in the same period a year ago.

The company had a gain of Rs 44.91 crore, shown as an exceptional item, in the quarter ended June this year.

Also Read | Xiaomi's Mi Browser Pro Reportedly Banned by Indian Government, Company Claims All Privacy Data Comply With Indian Law.

"We have reported strong performance across all our business in Q1 FY21 despite significant disruptions and ambiguity in the business environment due to COVID-19," Strides Pharma Science MD & CEO R Ananthanarayanan said.

"While our manufacturing and supply chain continue to remain steady without any significant disruptions, we remain cautiously optimistic on the outlook of our business for the year as the operating environment continues to evolve," he added.

Shares of Strides Pharma Science on Wednesday closed 14.22 per cent higher at Rs 534.50 per scrip on the BSE.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)